IDでもっと便利に新規取得

ログイン


ここから本文です

どこにフェーズ1完了とかいているのか?

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 51 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A First-in-Human, Multi-centre, Open-label, Phase 1 Clinical Study With RNA Oligonucleotide Drug MTL-CEBPA to Investigate Its Safety and Tolerability in Patients With Advanced Liver Cancer
Actual Study Start Date : March 1, 2016
Estimated Primary Completion Date : September 2018
Estimated Study Completion Date : December 2018